• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:SeHCAT 扫描诊断腹泻型肠易激综合征患者特发性胆汁酸吸收不良的患病率。

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

机构信息

Department of Nutrition & Dietetics, The Royal Marsden Hospital, London and Sutton, UK.

出版信息

Aliment Pharmacol Ther. 2009 Oct;30(7):707-17. doi: 10.1111/j.1365-2036.2009.04081.x. Epub 2009 Jun 30.

DOI:10.1111/j.1365-2036.2009.04081.x
PMID:19570102
Abstract

BACKGROUND

Recurrent, watery diarrhoea affects one-third of patients diagnosed with irritable bowel syndrome ('IBS-D'). Idiopathic bile acid malabsorption ('I-BAM') may be the cause.

AIM

To determine the prevalence of I-BAM in patients suffering from IBS-D.

METHODS

A systematic search was performed of publications reporting patients presenting with IBS-D type symptoms, who were subsequently confirmed as having I-BAM by SeHCAT scanning.

RESULTS

Eighteen relevant studies, 15 prospective, comprising 1223 patients were identified. Five studies (429 patients) indicated that 10% (CI: 7-13) patients had severe bile acid malabsorption (SeHCAT 7 day retention <5% of baseline value). 17 studies (1073 patients) indicated that 32% (CI: 29-35) patients had moderate bile acid malabsorption (SeHCAT <10%). 7 studies (618 patients) indicated that 26% (CI: 23-30) patients had mild (SeHCAT <15%) bile acid malabsorption. Pooled data from 15 studies showed a dose-response relationship according to severity of malabsorption to treatment with a bile acid binder: response to colestyramine occurred in 96% of patients with <5% retention, 80% at <10% retention and 70% at <15% retention.

CONCLUSIONS

Idiopathic adult-onset bile acid malabsorption is not rare. International guidelines for the management of irritable bowel syndrome need to be revised so that clinicians become more aware of this possibility.

摘要

背景

复发性水样腹泻影响三分之一被诊断为肠易激综合征(“IBS-D”)的患者。特发性胆汁酸吸收不良(“I-BAM”)可能是其病因。

目的

确定 IBS-D 患者中 I-BAM 的患病率。

方法

系统检索报告 IBS-D 型症状患者的文献,这些患者随后通过 SeHCAT 扫描被证实为 I-BAM。

结果

确定了 18 项相关研究,其中 15 项为前瞻性研究,共纳入 1223 例患者。5 项研究(429 例患者)表明,10%(95%CI:7-13)的患者存在严重胆汁酸吸收不良(7 天 SeHCAT 保留率<5%基线值)。17 项研究(1073 例患者)表明,32%(95%CI:29-35)的患者存在中度胆汁酸吸收不良(SeHCAT<10%)。7 项研究(618 例患者)表明,26%(95%CI:23-30)的患者存在轻度(SeHCAT<15%)胆汁酸吸收不良。15 项研究的汇总数据显示,根据吸收不良的严重程度与胆汁酸结合剂治疗的反应呈剂量反应关系:<5%保留率的患者对考来烯胺的反应率为 96%,<10%保留率的患者为 80%,<15%保留率的患者为 70%。

结论

特发性成人胆汁酸吸收不良并不罕见。国际肠易激综合征管理指南需要修订,以使临床医生更加意识到这种可能性。

相似文献

1
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.系统评价:SeHCAT 扫描诊断腹泻型肠易激综合征患者特发性胆汁酸吸收不良的患病率。
Aliment Pharmacol Ther. 2009 Oct;30(7):707-17. doi: 10.1111/j.1365-2036.2009.04081.x. Epub 2009 Jun 30.
2
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.用于研究胆汁酸吸收不良和测量胆汁酸池损失的 SeHCAT [牛磺熊脱氧胆酸(硒-75)]:系统评价和成本效益分析。
Health Technol Assess. 2013 Dec;17(61):1-236. doi: 10.3310/hta17610.
3
Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test.慢性腹泻患者的胆汁酸吸收不良:SeHCAT试验的临床价值
Scand J Gastroenterol. 2003 Aug;38(8):826-30. doi: 10.1080/00365520310004461.
4
Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.慢性腹泻中的胆汁酸吸收不良:病理生理学与治疗
Can J Gastroenterol. 2013 Nov;27(11):653-9. doi: 10.1155/2013/485631.
5
Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea.系统评价与荟萃分析:腹泻型肠易激综合征中胆汁酸吸收不良的患病率
Aliment Pharmacol Ther. 2015 Jul;42(1):3-11. doi: 10.1111/apt.13227. Epub 2015 Apr 27.
6
Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.胆汁酸吸收不良:腹泻型肠易激综合征症状患者中一种研究不足的鉴别诊断。
Scand J Gastroenterol. 2011 Jul;46(7-8):818-22. doi: 10.3109/00365521.2011.574728. Epub 2011 Apr 15.
7
Physical activity for treatment of irritable bowel syndrome.体力活动治疗肠易激综合征。
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
8
Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.具有功能性特征的慢性腹泻患者胆汁酸吸收不良的患病率:一项前瞻性研究。
BMC Gastroenterol. 2021 Feb 9;21(1):56. doi: 10.1186/s12876-021-01637-4.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
Management of bile acid diarrhea in Italy: a survey.意大利胆汁酸腹泻的管理:一项调查
Intern Emerg Med. 2025 Sep 12. doi: 10.1007/s11739-025-04060-9.
2
Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5-47 Months: A Retrospective Case Series.使用胆汁酸螯合剂治疗5至47个月的慢性肠病犬的粪便和临床特征:一项回顾性病例系列研究
J Vet Intern Med. 2025 Sep-Oct;39(5):e70206. doi: 10.1111/jvim.70206.
3
Bile Acid Diarrhea Is Associated With an Increased Risk of Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study.
胆汁酸腹泻与2型糖尿病和心血管疾病风险增加相关:一项全国性队列研究。
Clin Transl Gastroenterol. 2025 May 23;16(7):e00863. doi: 10.14309/ctg.0000000000000863. eCollection 2025 Jul 1.
4
Diet therapy (The 8×5 Diet) for adults living with bile acid diarrhoea: protocol for a feasibility randomised controlled trial.胆汁酸腹泻成年患者的饮食疗法(8×5饮食法):一项可行性随机对照试验方案
BMJ Open. 2025 Mar 27;15(3):e097973. doi: 10.1136/bmjopen-2024-097973.
5
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer.英国胃肠病学会关于癌症治疗所致急慢性胃肠道症状及并发症管理的实践指南。
Gut. 2025 Jun 6;74(7):1040-1067. doi: 10.1136/gutjnl-2024-333812.
6
Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide 1 Receptor Agonists: A Promising Yet Understudied Approach.用胰高血糖素样肽-1受体激动剂治疗胆汁酸腹泻:一种有前景但研究不足的方法。
Clin Transl Gastroenterol. 2025 Mar 1;16(3):e00815. doi: 10.14309/ctg.0000000000000815.
7
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid Diarrhea.利拉鲁肽和考来维仑在伴有胆酸腹泻患者的随机试验中改变血清和粪便胆汁酸水平。
Clin Transl Gastroenterol. 2024 Nov 1;15(11):e00772. doi: 10.14309/ctg.0000000000000772.
8
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.验证对罗马IV标准的简单修改在二级医疗保健中用于肠易激综合征诊断的有效性。
Aliment Pharmacol Ther. 2025 Jan;61(2):354-362. doi: 10.1111/apt.18363. Epub 2024 Oct 28.
9
A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.一种改善腹泻型肠易激综合征肠道内稳态的饮食营养新策略:肠道菌群与肠上皮相互作用的新视角。
Nutrients. 2024 Sep 21;16(18):3192. doi: 10.3390/nu16183192.
10
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review.调节肠道微环境作为肠易激综合征的一种治疗策略:一篇叙述性综述
Gut Microbiome (Camb). 2022 Aug 25;3:e7. doi: 10.1017/gmb.2022.6. eCollection 2022.